We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
9.48%
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Technology 6.61%
3 Industrials 5.39%
4 Communication Services 5.27%
5 Consumer Discretionary 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCPH
1501
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$6K ﹤0.01%
266
+190
+250% +$4.45K
VIA
1502
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$6K ﹤0.01%
+114
New +$5.7K
RUBY
1503
DELISTED
Rubius Therapeutics, Inc
RUBY
$6K ﹤0.01%
+352
New +$5.68K
TBIO
1504
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$6K ﹤0.01%
+478
New +$5.04K
CATO icon
1505
Cato Corp
CATO
$65.9M
$5K ﹤0.01%
400
+24
+6% +$327
CCL icon
1506
PUT
Carnival Corporation Ltd
CCL
$39.4B
$5K ﹤0.01%
100
-300
-75% -$15.7K
FLXS icon
1507
Flexsteel Industries
FLXS
$313M
$5K ﹤0.01%
+318
New +$6.53K
GLNG icon
1508
Golar LNG
GLNG
$5.19B
$5K ﹤0.01%
252
+58
+30% +$1.1K
GRVY
1509
GRAVITY
GRVY
$425M
$5K ﹤0.01%
+106
New +$7.22K
LMNR icon
1510
Limoneira
LMNR
$249M
$5K ﹤0.01%
+259
New +$5.53K
MGNX icon
1511
MacroGenics
MGNX
$255M
$5K ﹤0.01%
+272
New +$4.67K
MRUS
1512
DELISTED
Merus
MRUS
$5K ﹤0.01%
363
-15
-4% -$213
MTX icon
1513
Minerals Technologies
MTX
$2.34B
$5K ﹤0.01%
100
-35
-26% -$2.04K
TZOO icon
1514
Travelzoo
TZOO
$73.4M
$5K ﹤0.01%
+300
New +$5.05K
CBAY
1515
DELISTED
Cymabay Therapeutics
CBAY
$5K ﹤0.01%
+767
New +$8.69K
DBD
1516
DELISTED
Diebold Nixdorf Incorporated
DBD
$5K ﹤0.01%
590
+90
+18% +$939
CSII
1517
DELISTED
Cardiovascular Systems, Inc.
CSII
$5K ﹤0.01%
121
-498
-80% -$19.3K
AUY
1518
CALL
DELISTED
Yamana Gold, Inc.
AUY
$5K ﹤0.01%
+2,000
New +$4.4K
CCXI
1519
DELISTED
ChemoCentryx, Inc.
CCXI
$5K ﹤0.01%
+571
New +$6.61K
CATM
1520
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$5K ﹤0.01%
200
-855
-81% -$27.8K
AES icon
1521
AES
AES
$10.5B
$4K ﹤0.01%
237
-8
-3% -$136
ARVN icon
1522
Arvinas
ARVN
$560M
$4K ﹤0.01%
+166
New +$3.49K
BLFS icon
1523
BioLife Solutions
BLFS
$1.66B
$4K ﹤0.01%
248
-4,584
-95% -$79.9K
FIZZ icon
1524
National Beverage
FIZZ
$2.99B
$4K ﹤0.01%
+200
New +$5.14K
GPRO icon
1525
GoPro
GPRO
$126M
$4K ﹤0.01%
+700
New +$4.45K

Similar funds

Prelude Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.

  • Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
  • Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
  • Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
  • Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
  • Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
  • Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.